Gastrointestinal CancerPhysical activity and mortality in patients with colorectal cancer: a meta-analysis of prospective cohort studiesQiu, Shumina; Jiang, Chongminb; Zhou, LincAuthor Information aSchool of Sport Economics and Management, Central University of Finance and Economics bYouth Sports Research Center, China Institute of Sport Science, Beijing cDepartment of Gastroenterology, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan Province, People’s Republic of China Received 11 October 2018 Accepted 4 March 2019 Supplemental digital content is available for this article. Direct URL citationsappear in the printed text and are provided in the HTML and PDF versions of thisarticle on the journal’s website, www.eurjcancerprev.com. Correspondence to Shumin Qiu, PhD, School of Sport Economics and Management, Central University of Finance and Economics, 39 South College Road, Haidian District, 100081 Beijing, People’s Republic of China Tel: + 86 010 622 8542; fax: + 86 010 622 88138; e-mail: [email protected] European Journal of Cancer Prevention: January 2020 - Volume 29 - Issue 1 - p 15-26 doi: 10.1097/CEJ.0000000000000511 Buy SDC Metrics Abstract The association between physical activity (PA) and colorectal cancer (CRC) patients’ survival is inconsistent. We conducted a systematic review and meta-analysis to summarize published articles on this issue. We performed a comprehensive search of the PubMed, Embase, and Web of Science databases for relevant articles through 28 February 2018. The summary hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using a random-effects model. Eighteen prospective cohort studies were included in the meta-analysis, with a total of 9257 cases of total mortality (TM) and 4015 cases of colorectal cancer-specific mortality (CRCSM) among 31 873 CRC survivors and 557 150 general populations. Among CRC survivors, the highest versus the lowest levels of prediagnosis PA showed decreased risks of TM (summary HR = 0.81, 95% CI: 0.76–0.87, I2 = 1.8%) and CRCSM (summary HR = 0.85, 95% CI: 0.77–0.98, I2 = 0), respectively. Significant risk reductions for TM and CRCSM were also demonstrated for postdiagnosis PA (HR = 0.63, 95% CI: 0.54–0.74; and HR = 0.64, 95% CI: 0.47–0.88, respectively). The inverse association between prediagnosis PA and cancer mortality was more pronounced for colon cancer than that for rectal cancer (P = 0.08). The summary HRs (95% CIs) of TM were 0.89 (0.83–0.97) and 0.79 (0.69–0.90) per 10 metabolic equivalent task-h/week increase in prediagnosis and postdiagnosis PA, respectively. Our meta-analysis provides comprehensive evidence that PA performed before or after cancer diagnosis is related to reduced mortality risk among CRC survivors. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.